Friday - In a recent update, RBC Capital analysts have maintained their Outperform rating on Boston Scientific (NYSE:BSX) shares, with a steady price target of $105.00. The stock, currently ...

In a report released yesterday, Shagun Singh Chadha from RBC Capital reiterated a Buy rating on Boston Scientific (BSX – Research Report), with ...

RBC Capital lowered the firm’s price target on Boston Beer (SAM) to $295 from $318 and keeps a Sector Perform rating on the shares as part of a broader research note previewing Q4 results across ...

Friday - In a recent update, RBC Capital analysts have maintained their Outperform rating on Boston Scientific (NYSE:BSX) shares, with a steady price target of $105.00. The stock, currently trading at ...